Company Filing History:
Years Active: 2008
Title: Wade Aaron - Innovator in Antibody Technology
Introduction
Wade Aaron is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific peptides. His work has implications for the treatment and management of hyperproliferative disorders.
Latest Patents
Wade Aaron holds a patent for "Anti-galanin antibodies and uses thereof." This invention provides antibodies that immunospecifically bind to a galanin peptide. The patent outlines methods for preventing, treating, managing, and ameliorating hyperproliferative disorders or symptoms thereof by administering these antibodies to subjects in need. Additionally, the invention includes methods and compositions for diagnosing, monitoring, and prognosing hyperproliferative disorders. It also relates to articles of manufacture and kits that comprise these antibodies.
Career Highlights
Wade Aaron is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the field of antibody technology. His contributions have been instrumental in advancing therapeutic options for patients with specific medical conditions.
Collaborations
Wade has collaborated with notable colleagues, including Richard J. Austin and Cynthia L. Hart. These collaborations have fostered a productive environment for research and development, enhancing the impact of their collective work in biotechnology.
Conclusion
Wade Aaron's innovative work in antibody technology exemplifies the potential of scientific research to address complex medical challenges. His patent on anti-galanin antibodies represents a significant advancement in the treatment of hyperproliferative disorders.